Moderna
MRNA
$43.17
Share price
8.24%
Change (1 day)
-74.36%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Earnings for Moderna (MRNA)
Earnings in 2024 (TTM): -A$5.54 Billion
According to Moderna 's latest financial reports the company's current earnings are A$3.19 Billion. , an increase over its 2023 earnings that were of -A$6.32 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Moderna from 2018 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -A$5.8 Billion | -8.22% |
| 2023 | -A$6.32 Billion | -140.65% |
| 2022 | A$15.54 B | -27.81% |
| 2021 | A$21.53 B | -1911.15% |
| 2020 | -A$1.19 Billion | 44.7% |
| 2019 | -A$0.83 Billion | 28.63% |
| 2018 | -A$0.64 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -A$74.79 Million | -98.71% | 🇺🇸 USA |
 | A$34.32 B | -691.88% | 🇺🇸 USA |
 | -A$67.61 Million | -98.83% | 🇺🇸 USA |
 | -A$0.39 Billion | -93.43% | 🇺🇸 USA |
 | A$22.07 B | -480.69% | 🇨🇭 Switzerland |
 | -A$0.98 Billion | -83.25% | 🇺🇸 USA |
 | A$28.23 B | -586.80% | 🇺🇸 USA |
 | -A$0.2 Billion | -96.72% | 🇺🇸 USA |